STAT+: How $500 explains Republican health policy, and the GLP-1 Rx wave
Reported by STAT News · all stories from statnews.com
Editorial digest
This story explores how a specific $500 figure helps to explain current Republican healthcare policy approaches. It also covers the growing trend in prescriptions for GLP-1 class medications.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom9/30/2026
STAT+: What health tech leaders are talking about in Washington policy circles
Leaders in health technology are discussing policy matters in Washington.
- Trusted health newsroom10/22/2026
STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction
Virtual clinics are providing off-label GLP-1 therapies for substance use disorders before receiving formal regulatory authorization.
- Trusted health newsroom10/7/2026
STAT+: Why health AI pilots in Utah may be on a collision course with the FDA
Utah's healthcare artificial intelligence trials may conflict with federal regulatory bodies.
- Trusted health newsroom10/5/2026
STAT+: Utah plows ahead with more health AI pilots for prescriptions, women’s health
Utah continues expanding health AI pilot programs for prescriptions and women's health.
- Trusted health newsroom10/22/2026
STAT+: FDA finalizes its guidance on apps related to drugs, pharma rejoices
Federal regulators have completed formal guidelines for software applications paired with medications, drawing positive reactions from pharmaceutical manufacturers.
- Trusted health newsroom10/14/2026
STAT+: Lobbyists and trade groups fight to shape how states regulate medical AI
Industry representatives are working to influence state-level medical artificial intelligence rules.